Intricon (IIN) 10-Q 15 May 17 2017 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2017	Apr. 30, 2017
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q1
Entity Registrant Name	INTRICON CORP
Entity Central Index Key	88,790
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		6,843,829

Consolidated Condensed Balance

Consolidated Condensed Balance Sheets - USD ($) $ in Thousands		Mar. 31, 2017	Dec. 31, 2016
Current assets:
Cash		$ 380	$ 667
Restricted cash		612	595
Accounts receivable, less allowance for doubtful accounts of $167 at March 31, 2017 and $170 at December 31, 2016		8,129	7,289
Inventories		13,239	12,343
Other current assets		1,104	957
Current assets of discontinued operations			123
Total current assets		23,464	21,974
Machinery and equipment		40,202	40,152
Less: Accumulated depreciation		33,755	33,546
Net machinery and equipment		6,447	6,606
Goodwill		10,555	10,555
Intangible assets, net		2,856	2,920
Investment in partnerships		238	146
Other assets, net		1,447	1,557
Total assets	[1]	45,007	43,758
Current liabilities:
Current maturities of long-term debt		2,368	2,346
Accounts payable		8,403	6,722
Accrued salaries, wages and commissions		2,171	2,413
Other accrued liabilities		1,785	1,914
Liabilities of discontinued operations			123
Total current liabilities		14,727	13,518
Long-term debt, less current maturities		9,830	9,284
Other postretirement benefit obligations		490	501
Accrued pension liabilities		730	737
Other long-term liabilities		691	707
Total liabilities	[1]	26,468	24,747
Commitments and contingencies
Shareholders' equity:
Common stock, $1.00 par value per share; 20,000 shares authorized; 6,836 and 6,820 shares issued and outstanding at March 31, 2017 and December 31, 2016, respectively		6,836	6,820
Additional paid-in capital		21,646	21,383
Accumulated deficit		(9,061)	(8,633)
Accumulated other comprehensive loss		(952)	(1,014)
Total shareholders' equity		18,469	18,556
Non-controlling interest		70	455
Total equity		18,539	19,011
Total liabilities and equity		$ 45,007	$ 43,758
[1]	Assets of Hearing Help Express (HHE), a consolidated variable interest entity, that can only be used to settle obligations of HHE were $5,040 at March 31, 2017 and $5,159 at December 31, 2016, respectively. Liabilities of HHE, for which creditors do not have recourse to the general credit of IntriCon, were $4,166 at March 31, 2017 and $3,833 at December 31, 2016, respectively.

Consolidated Condensed Balance3

Consolidated Condensed Balance Sheets (Parenthetical) - USD ($) $ in Thousands		Mar. 31, 2017	Dec. 31, 2016
Accounts receivable, allowance for doubtful accounts		$ 167	$ 170
Common shares, par value		$ 1	$ 1
Common shares, shares authorized		20,000,000	20,000,000
Common shares, shares issued		6,836,000	6,820,000
Common shares, shares outstanding		6,836,000	6,820,000
Assets	[1]	$ 45,007	$ 43,758
Liabilities	[1]	26,468	24,747
Hearing Help Express (HHE) [Member]
Assets		5,040	5,159
Liabilities		$ 4,166	$ 3,833
[1]	Assets of Hearing Help Express (HHE), a consolidated variable interest entity, that can only be used to settle obligations of HHE were $5,040 at March 31, 2017 and $5,159 at December 31, 2016, respectively. Liabilities of HHE, for which creditors do not have recourse to the general credit of IntriCon, were $4,166 at March 31, 2017 and $3,833 at December 31, 2016, respectively.

Consolidated Condensed Statemen

Consolidated Condensed Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Consolidated Statements of Operations [Abstract]
Sales, net	$ 20,088	$ 18,064
Cost of sales	14,412	12,966
Gross profit	5,676	5,098
Operating expenses:
Sales and marketing	2,311	1,156
General and administrative	2,558	2,266
Research and development	1,153	1,165
Total operating expenses	6,022	4,587
Operating income (loss)	(346)	511
Interest expense	(182)	(126)
Other income (expense)	56	(70)
Income (loss) from continuing operations before income taxes and discontinued operations	(472)	315
Income tax expense	64	34
Income (loss) from continuing operations before discontinued operations	(536)	281
Loss on sale of discontinued operations (Note 3)	(164)
Loss from discontinued operations (Note 3)	(113)	(300)
Net loss	(813)	(19)
Less: Loss allocated to non-controlling interest	(385)	(34)
Net income (loss) attributable to IntriCon shareholders	$ (428)	$ 15
Basic income (loss) per share attributable to IntriCon shareholders:
Continuing operations	$ (0.02)	$ 0.05
Discontinued operations	(0.04)	(0.05)
Net income (loss) per share:	(0.06)	0
Diluted income (loss) per share attributable to IntriCon shareholders:
Continuing operations	(0.02)	0.05
Discontinued operations	(0.04)	(0.05)
Net income (loss) per share:	$ (0.06)	$ 0
Average shares outstanding:
Basic	6,826	5,981
Diluted	6,826	6,228

Consolidated Condensed Stateme5

Consolidated Condensed Statements Of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Consolidated Statements of Comprehensive Income (Loss) [Abstract]
Net loss	$ (813)	$ (19)
Interest rate swap, net of taxes of $0	12	(37)
Pension and postretirement obligations, net of taxes of $0	5	5
Foreign currency translation adjustment, net of taxes of $0	45	30
Comprehensive loss	$ (751)	$ (21)

Consolidated Condensed Stateme6

Consolidated Condensed Statements Of Comprehensive Income (Loss) (Parenthetical) $ in Thousands	15 Months Ended
	Mar. 31, 2017USD ($)
Consolidated Statements of Comprehensive Income (Loss) [Abstract]
Interest rate swap, tax	$ 0
Pension and postretirement obligations, tax	0
Foreign currency translation adjustment, tax	$ 0

Consolidated Condensed Stateme7

Consolidated Condensed Statements Of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net loss	$ (813)	$ (19)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	562	494
Stock-based compensation	218	181
Change in deferred gain		(28)
Loss on sale of discontinued operations	164
Change in allowance for doubtful accounts	(3)	1
Equity in loss of partnerships	12	54
Changes in operating assets and liabilities:
Accounts receivable	(888)	(629)
Inventories	(905)	(85)
Other assets	(121)	(454)
Accounts payable	1,670	492
Accrued expenses	(531)	(913)
Other liabilities	51	(25)
Net cash used in operating activities	(584)	(931)
Cash flows from investing activities:
Purchases of property, plant and equipment	(273)	(624)
Other	(94)	(18)
Net cash used in investing activities	(367)	(642)
Cash flows from financing activities:
Proceeds from long-term borrowings	4,520	3,628
Repayments of long-term borrowings	(3,920)	(1,951)
Proceeds from employee stock purchases and exercise of stock options	60	24
Change in restricted cash	(21)	(42)
Net cash provided by financing activities	639	1,659
Effect of exchange rate changes on cash	25	100
Net increase (decrease) in cash	(287)	186
Cash, beginning of period	667	367
Cash, end of period	$ 380	$ 553

General

General	3 Months Ended
	Mar. 31, 2017
General [Abstract]
General	1. General  In the opinion of management, the accompanying consolidated condensed financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly IntriCon Corporation's (“IntriCon” or the “Company”) consolidated financial position as of March 31, 201 7 and December 31, 2016 , and the consolidated results of its operations and cash flows for the three months ended March 31, 201 7 and 20 16 . Results of operations for the interim periods are not necessarily indicative of the results of operations expected for the full year or any other interim period.  In December 2016, the Company’s board of directors approved plans to discontinue its cardiac diagnostic monitoring business. The Company sold the cardiac diagnostic monitoring business on February 17, 2017 to Datrix, LLC. For all periods presented, the Company classified this business as discontinued operations, and, accordingly, has reclassified historical financial data presented herein.  The consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All material intercompany transactions and balances have been eliminated in consolidation. The Company evaluates its voting and variable interests in entities on a qualitative and quantitative basis. The Company consolidates entities in which it concludes it has the power to direct the activities that most significantly impact an entity’s economic success and has the obligation to absorb losses or the right to receive benefits that could be significant to the entity.  On January 19, 2017, the Company announced that it had exercised its option to acquire the remaining 80 percent stake in Hearing Help Express. The transaction is expect ed to close in 2017. The results of Hearing Help Express are consolidated into the Company’s financial statements as of October 31, 2016.  In April 2017, we entered into an agreement to acquire a 49 percent stake in Soundperience. Soundperience has designed state of the art self-fitting hearing aid technology. The company’s self-fitting hearing aid technology is being used in the German market today, most notably though our Signison joint venture with Soundperience. Both Soundperience and Signison will be accounted in the Company’s financial statements using the equity method.  The Company notes Hearing Help Express’s pro forma financial statements were not included for 2016 as this company was in bankruptcy and this year was not reflective of the normal operations of Hearing Help Express.  The Company has evaluated subsequent events occurring after the date of the consolidated financial statements for events requiring recording or disclosure in the financial statements.

New Accounting Pronouncements

New Accounting Pronouncements	3 Months Ended
	Mar. 31, 2017
New Accounting Pronouncements [Abstract]
New Accounting Pronouncements	2. New Accounting Pronouncements  In January 2017, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2017-04 “Intangibles — Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” This new standard simplifies the accounting for goodwill impairments by eliminating step 2 from the goodwill impairment test. The amendments in this update are effective for annual impairment tests in fiscal years beginning after December 15, 2019. Early adoption is permitted for goodwill impairment tests performed on or after January 1, 2017. The Company does not anticipate that the adoption of this new standard will have a material impact on its consolidated financial statements.  In November 2016, the FASB issued ASU No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash, a consensus of the FASB’s Emerging Issues Task Force (the “Task Force”). The new standard requires that the statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Entities will also be required to reconcile such total to amounts on the balance sheet and disclose the nature of the restrictions. The Company does not anticipate that the adoption of this new standard will have a material impact on its consolidated financial statements.  In March 2016, the FASB issued ASU 2016-9, Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting, which simplifies several aspects of the accounting for shared-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. For public entities, this ASU is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The adoption of the guidance does not have a material impact on our financial statements. In February 2016, the FASB issued its final standard on accounting for leases. This standard, issued as ASU 2016-02, requires that an entity that is a lessee recognize lease assets and lease liabilities on the balance sheet for all leases and disclose key information about leasing arrangements. This update is effective for financial statement periods beginning after December 15, 2018, with earlier application permitted. The Company has not yet determined the impact of this pronouncement on its consolidated financial statements and related disclosures.  In May 2014, the FASB issued new accounting guidance related to revenue recognition. This new standard will replace all current U.S. GAAP guidance on this topic and eliminate all industry-specific guidance. The new revenue recognition standard provides a unified model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. This guidance will be effective for the Company beginning January 1, 2018 and can be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. The Company has established a timeline related to the implementation of the standard and believes the timeline is sufficient to implement the new standard. We are currently assessing the impact on the Company’s consolidated financial statements.

Discontinued Operations

Discontinued Operations	3 Months Ended
	Mar. 31, 2017
Discontinued Operations [Abstract]
Discontinued Operations	3. Discontinued Operations The following table shows the cardiac diagnostic monitoring business balance sheet as of December 31, 2016:    December 31,  2016  Accounts receivable, net $ 123  Current assets of discontinued operations $ 123   Accounts payable 22  Accrued compensation and other liabilities 101  Current liabilities of discontinued operations $ 123  The following table shows the results of the cardiac diagnostic monitoring discontinued operation s:    Three Months Ended  March 31, March 31,  2017 2016   Sales, net $ 140 $ 194  Operating costs and expenses (253) (494)  Net loss from discontinued operations (113) (300)  The Company sold the cardiac diagnostic monitoring business on F ebruary 17, 2017 to Datrix, LLC for a future revenue earn-out that was valued by the Company at $0. The Company recorded a loss on the sale of $164. The net loss was computed as follows:     Accounts receivable, net $ 179  Accrued liabilities (15)  Net assets sold $ 164  Fair value of consideration received -  Loss on sale of discontinued operations, net of income taxes $ 164 

Segment Reporting

Segment Reporting	3 Months Ended
	Mar. 31, 2017
Segment Reporting and Geogrpahic Information [Abstract]
Segment Reporting	4. Segment Reporting  The Company currently operates in two reportable segments: body-worn devices and hearing health direct-to-consumer. The nature of distribution and services has been deemed separately identifiable. Therefore, segment reporting has been applied. Income (loss) from operations is total net revenues less cost of sales and operating expenses. Identifiable assets by industry segment include assets directly identifiable with those operations. The accounting policies applied to determine segment information are the same as those described in the summary of significant accounting policies described in and incorporated by reference from “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Note 1 to the financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 . The Company evaluates the performance of each segment based on income and loss from continuing operations before income taxes. The following table summarizes data by industry segment:      At and for the Three Months Ended March 31, 2017 Body Worn Devices Hearing Health Direct-to-Consumer Total  Revenue, net $ 18,672 $ 1,416 $ 20,088  Loss from continuing operations (83) (453) (536)  Identifiable assets (excluding goodwill) 30,416 4,036 34,452  Goodwill 9,551 1,004 10,555  Depreciation and amortization 495 67 562  Capital expenditures 213 60 273  

Geographic Information

Geographic Information	3 Months Ended
	Mar. 31, 2017
Segment Reporting and Geogrpahic Information [Abstract]
Geographic Information	5. Geographic Information  The geographical distribution of long-lived assets to geographical areas consisted of the following at:     March 31, December 31,  2017 2016  United States $ 4,572 $ 4,640  Singapore 1,339 1,413  Other – primarily United Kingdom and Indonesia 536 553  Consolidated $ 6,447 $ 6,606    Long-lived assets consist of property and equipment. Excluded from long-lived assets are investments in partnerships, patents, license agreements, intangible assets and goodwill. The Company capitalizes long-lived assets pertaining to the production of specialized parts. These assets are periodically reviewed to assure the net realizable value from the estimated future production based on forecasted cash flows exceeds the carrying value of the assets.  The geographical distribution of net sales to geographical areas for the three months ended March 31, 201 7 and 2016 were as follows:       Three Months Ended  Net Sales to Geographical Areas March 31, 2017 March 31, 2016   United States $ 15,523 $ 11,730  Europe 2,478 3,297  Asia 1,910 2,868  All other countries 177 169  Consolidated $ 20,088 $ 18,064  Geographic net sales are allocated based on the location of the customer. All other countries include net sales primarily to various countries in Eu rope and in the Asia Pacific region. For the three months ended March 31, 2017 , one customer accounted for 46% of the Company’s consolidated net sales. For the three months ended March 31, 2016, one customer accounted for 39 % of the Company’s consolidated net sales. At March 31, 2017 , two customers combined accounted for 31% of the Company’s consolidated accounts receivable. At December 31, 2016, two customers combined accounted for 31% of the Company’s consolidated accounts receivable.

Inventories

Inventories	3 Months Ended
	Mar. 31, 2017
Inventories [Abstract]
Inventories	6 . Inventories Inventories consisted of the following at:     Raw materials Work-in process Finished products and components Total  March 31, 2017  Domestic $ 6,212 $ 1,401 $ 2,955 $ 10,568  Foreign 1,583 369 719 2,671  Total $ 7,795 $ 1,770 $ 3,674 $ 13,239   December 31, 2016  Domestic $ 5,731 $ 1,324 $ 2,609 $ 9,664  Foreign 1,751 284 644 2,679  Total $ 7,482 $ 1,608 $ 3,253 $ 12,343 

Short And Long-Term Debt

Short And Long-Term Debt	3 Months Ended
	Mar. 31, 2017
Short And Long-Term Debt [Abstract]
Short And Long-Term Debt	7 . Short and Long-Term Debt  Short and long-term debt is summarized as follows:       March 31, December 31,  2017 2016   Domestic asset-based revolving credit facility $ 4,078 $ 3,218  Note payable 2,000 2,000  Foreign overdraft and letter of credit facility 1,247 1,243  Domestic term loan 5,000 5,250  Unamortized finance costs (127) (81)  Total debt 12,198 11,630  Less: current maturities (2,368) (2,346)  Total long-term debt $ 9,830 $ 9,284  D omestic Credit Facilities The Company and its domestic subsidiaries are parties to a credit facility with The PrivateBank and Trust Company. The credit facility, as amended through March 31, 2017, provides for: § a $9,000 revolving credit facility, with a $200 sub facility for letters of credit. Under the revolving credit facility, the availability of funds depends on a borrowing base composed of stated percentages of the Company’s eligible trade receivables and eligible inventory, and eligible equipment less a reserve; and  § a term loan in the original amount of $6,000 . On March 9, 2017, the Company and its domestic subsidiary, IntriCon, Inc., entered into a Tenth Amendment to the Loan and Security Agreement and Waiver (the “Tenth Amendment”) with The PrivateBank and Trust Company. The Tenth Amendment, among other things: § amended the minimum EBITDA (as defined in the Loan and Security Agreement), funded debt to EBITDA ratio and fixed charge coverage ratio covenants; and  § waived defaults in the funded debt to EBITDA ratio and fixed charge coverage ratio covenants as of December 31, 2016.  All of the borrowings under this agreement have been characterized as either a current or long-term liability on our balance sheet in accordance with the repayment terms described more fully below. Weighted average interest on the revolving credit facility was 6.82% for the three months ended March 31, 2017 and 4.36% for the year ended December 31, 2016. The outstanding balance of the revolving credit facility was $4,078 and $3,218 at March 31, 2017 and December 31, 2016, respect ively. The total availability on the revolving credit facility was approximately $4,508 and $5,121 at March 31, 2017 and December 31, 2016, respectively. The outstanding principal balance of the term loan, as amended, is payable in quarterly installments of $250 . Any remaining principal and accrued interest is payable on February 28, 2019. IntriCon is also required to use 100% of the net cash proceeds of certain asset sales (excluding inventory and certain other dispositions), sale of capital securities or issuance of debt to pay down the term loan.  The Company was in compliance with the financial covenants under the facility as of March 31, 2017.  Foreign Credit Facility  In addition to its domestic credit facilities, the Company’s wholly-owned subsidiary, IntriCon, PTE LTD., entered into an international senior secured credit agreement with Oversea-Chinese Banking Corporation Ltd. that provides for an asset based line of credit. Borrowings bear interest at a rate of .75% to 2.5% over the lender’s prevailing prime lending rate. Weighted average interest on the international credit facilities was 3.87% and 3.50% for the three months ended March 31, 2017 and the year ended December 31, 2016, respectively. The outstanding balance was $1,247 and $1,243 at March 31, 2017 and December 31, 2016, respectively. The total remaining availability on the international senior secured credit agreement was approximately $476 and $455 at March 31, 2017 and December 31, 2016 , respectively.  Note Payable Hearing Help Express has a $2,000 note payable to a party holding 80% of its equity interest. The note is secured by substantially all of the assets of Hearing Help Express. The note is payable over 48 months in quarterly installments with interest at 5% per year, except that interest only will be paid in the first twelve months, with the deferred payments to be made at maturity.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2017
Income Taxes [Abstract]
Income taxes	8 . Income Taxes  Income tax expense for the three months ended March 31, 201 7 was $ 64 compared to $ 34 for the same period in 201 6 . The expense for the three months ended March 31, 201 7 and 201 6 , was primarily due to foreign operations. The Company has net operating loss carryforwards for U.S. federal income tax purposes and, consequently, minimal federal benefit or expense from the domestic operations was recognized as the deferred tax asset has a full valuation allowance.  The following was the income (loss) before income taxes for each jurisdiction in which the Company has operations for the three months ended March 31, 201 7 and 2016 .      Three Months Ended  March 31, 2017 March 31, 2016  United States $ (387) $ (32)  Singapore (93) 204  Indonesia 16 18  United Kingdom (125) 55  Germany 117 70  Income (loss) before income taxes $ (472) $ 315 

Shareholders' Equity And Stock-

Shareholders' Equity And Stock-Based Compensation	3 Months Ended
	Mar. 31, 2017
Common Stock And Stock Options [Abstract]
Shareholders' Equity And Stock-Based Compensation	9. Shareholders’ Equity and Stock-based Compensation  The Company has a 2006 Equity Incentive Plan and a 2015 Equity Incentive Plan. The 2015 Equity Incentive Plan replaced the 2006 Equity Incentive Plan and new grants may not be made under the 2006 Plan. Under the 2015 Equity Incentive Pan, the Company may grant stock options, stock awards, stock appreciation rights, restricted stock units and other equity-based awards, although no such awards, other than stock options , had been granted as of March 31, 2017. Under all awards, the terms are fixed on the grant date. Generally, the exercise price of stock options equals the market price of the Company’s stock on the date of the grant. Options under the plans generally vest over three years, and have a maximum term of 10 years.  T he Compensation Committee of the Board of Directors has established a non-employee directors’ stock fee election program, referred to as the director’s program, and a non-employee director and executive officer stock purchase program, referred to as the management purchase program, as an award under the 2015 Plan. There were no shares purchased under the director program or the management purchase program during the three months ended March 31, 2017 and 2016.  Stock option activity as of and during the three months ended March 31, 201 7 was as follows:      Weighted-average Aggregate  Number of Shares Exercise Price Intrinsic Value   Outstanding at December 31, 2016 1,385 $ 6.54  Options forfeited, cancelled or expired (4) 7.38  Options granted 145 6.90  Options exercised (26) 5.09   Outstanding at March 31, 2017 1,500 $ 6.60 $ 4,463   Exercisable at March 31, 2017 1,116 $ 6.48 $ 3,641   Available for future grant at December 31, 2016 404   Available for future grant at March 31, 2017 272  The number of shares available for future grants at March 31, 201 7 does not include a total of up to 1, 124 shares subject to options outstanding under the 2006 plan as of March 31, 201 7 , which will become available for grant under the 2015 Equity Incentive Plan in the event of the expiration, cancellation or surrender of such options.  The fair value of each stock option granted is estimated on the date of grant using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. In addition, option-pricing models require the input of subjective assumptions, including the expected stock price volatility. The weighted average fair value of options granted was $3.98 for options granted during the three months ended March 31, 2017 . The weighted average fair value of options granted was $ 7.58 for options granted during the three months ended March 31, 2016.  The Company calculates expected volatility for stock options and awards using the Company’s historical volatility.  The Company currently estimates a zero percent forfeiture rate for stock opti ons .  The risk-free rates for the expected terms of the stock options and awards are based on the U.S. Treasury yield curve in effect at the time of grant.  The weighted average remaining contractual life of options outstanding and exercisable was 4.36 years and 5.33 years as of March 31, 2017 and December 31, 2016, respectively.  The Company recorded $ 218 of non-cash stock option expense for the three months ended March 31, 2017 . The Company recorded $ 181 of non-cash stock option expense for the three months ended March 31, 2016. As of March 31, 201 7 , there was $1,247 of total unrecognized compensation costs related to non-vested awards that are expected to be recognized over a weighted-average period of 2.04 years.  The Company also has an Employee Stock Purchase Plan (the “Purchase Plan”). The Purchase Plan, as amended, through March 31, 2017 , provides that a maximum of 300 shares may be sold under the Purchase Plan. There were a total of 4 shares purchased under the plan for the three months ended March 31, 2017 and a total of 4 shares purchased for the three months ended March 31, 2016.

Income (Loss) Per Share

Income (Loss) Per Share	3 Months Ended
	Mar. 31, 2017
Income (Loss) Per Share [Abstract]
Income (Loss) Per Share	10 . Income (loss) Per Share  The following table presents a reconciliation between basic and diluted earnings per share:       Three Months Ended  March 31, 2017 March 31, 2016  Numerator:  Income (loss) from continuing operations before income taxes and discontinued operations $ (536) $ 281  Loss on sale of discontinued operations (164)  Loss from discontinued operations, net of income taxes (113) (300)   Net loss (813) (19)   Less: loss allocated to non-controlling interest (385) (34)   Net income (loss) attributable to shareholders $ (428) $ 15   Denominator:  Basic – weighted shares outstanding 6,826 5,981  Weighted shares assumed upon exercise of stock options - 247  Diluted – weighted shares outstanding 6,826 6,228   Basic income (loss) per share attributable to IntriCon shareholders:  Continuing operations $ (0.02) $ 0.05  Discontinued operations (0.04) $ (0.05)  Net income (loss) per share: $ (0.06) $ 0.00   Diluted income (loss) per share attributable to IntriCon shareholders:  Continuing operations $ (0.02) $ 0.05  Discontinued operations (0.04) $ (0.05)  Net income (loss) per share: $ (0.06) $ 0.00  The dilutive impact summarized above relates to the periods when the average market price of Company stock exceeded the exercise price of the potentially dilutive option securities granted. Earnings per common share was based on the weighted average number of common shares outstanding during the periods when computing the basic earnings per share. When dilutive, stock options are included as equivalents using the treasury stock method when computing the diluted earnings per share. Individual components of basic and diluted income (loss) per share may not sum to the total income (loss) per share due to rounding .  Excluded from the computation of diluted earnings per share for the three months ended March 31, 2017 were outstanding in the money options to purchase approximately 294 common shares because the effect would have been anti-dilutive due to the Company’s net income (loss) in the period.

Legal Proceedings

Legal Proceedings	3 Months Ended
	Mar. 31, 2017
Contigencies And Commitments [Abstract]
Legal Proceedings	11 . Legal Proceedings  The Company is a defendant along with a number of other parties in lawsuits alleging that plaintiffs have or may have contracted asbestos-related diseases as a result of exposure to asbestos products or equipment containing asbestos sold by one or more named defendants. These lawsuits relate to the discontinued heat technologies segment which was sold in March 2005. Due to the non-informative nature of the complaints, the Company does not know whether any of the complaints state valid claims against the Company. Certain insurance carriers have informed the Company that the primary policies for the period August 1, 1970-1978 have been exhausted and that the carriers will no longer provide defense and insurance coverage under those policies. However, the Company has other primary and excess insurance policies that the Company believes afford coverage for later years. Some of these other primary insurers have accepted defense and insurance coverage for these suits, and some of them have either ignored the Company’s tender of defense of these cases, or have denied coverage, or have accepted the tenders but asserted a reservation of rights and/or advised the Company that they need to investigate further. Because settlement payments are applied to all years a litigant was deemed to have been exposed to asbestos, the Company believes that it will have funds available for defense and insurance coverage under the non-exhausted primary and excess insurance policies. However, unlike the older policies, the more recent policies have deductible amounts for defense and settlements costs that the Company will be required to pay; accordingly, the Company expects that its litigation costs will increase in the future. Further, many of the policies covering later years (approximately 1984 and thereafter) have exclusions for any asbestos products or operations, and thus do not provide insurance coverage for asbestos-related lawsuits. The Company does not believe that the asserted exhaustion of some of the primary insurance coverage for the 1970-1978 period will have a material adverse effect on its financial condition, liquidity, or results of operations. Management believes that the number of insurance carriers involved in the defense of the suits, and the significant number of policy years and policy limits under which these insurance carriers are insuring the Company, make the ultimate disposition of these lawsuits not material to the Company's consolidated financial position or results of operations.  The Company’s former French subsidiary, Selas SAS, filed for insolvency in France. The Company may be subject to additional litigation or liabilities as a result of the French insolvency proceeding , including liabilities under guarantees aggregating approximatel y $4 50 .  The Company is also involved in other lawsuits arising in the normal course of business. While it is not possible to predict with certainty the outcome of these matters, management is of the opinion that the disposition of these lawsuits and claims will not materially affect our consolidated financial position, liquidity or results of operations. 

Related-Party Transactions

Related-Party Transactions	3 Months Ended
	Mar. 31, 2017
Related-Party Transactions [Abstract]
Related-Party Transactions	12 . Related-Party Transactions  On March 10, 2017, the Company’s entered into a Fourth Extension Agreement to the Amended and Restated Office/Warehouse Lease with Arden Partners I, L.L.P., the landlord of the Company’s facility in Arden Hills, Minnesota. Pursuant to the lease as amended, the Company leases office and factory space from a partnership consisting of three present or f ormer officers of the Company , including Mark Gorder, a member of the Company’s Board of Directors and the President and Chief Executive Officer of the Company. The Company is required to pay all real estate taxes and operating expenses . The total base rent expense, real estate taxes and other charges incurred under the lease were approximately $ 124 for the three months ended March 31, 2017 and approximately $ 121 for the three months ended March 31, 2016. The term of the lease runs to January 31, 2022.  The Company uses the law firm of Blank Rome LLP for legal services. A partner of that firm is the son-in-law of the Chairman of the Company’s Board of Directors. For the three months ended March 31, 2017 , the Company paid that firm approximately $ 72 for legal services and costs. For the three months ended March 31, 2016, the Company paid that firm approximately $67 for legal services and costs. The Chairman of our Board of Directors is considered independent under applicable Nasdaq and Securities and Exchange Commission rules because (i) no payments were made to the Chairman or the partner directly in exchange for the services provided by the law firm and (ii) the amounts paid to the law firm did not exceed the thresholds contained in the Nasdaq standards. Furthermore, the aforementioned partner does not provide any legal services to the Company and is not involved in billing matters.

Revenue By Market

Revenue By Market	3 Months Ended
	Mar. 31, 2017
Revenue By Market [Abstract]
Revenue By Market	13 . Revenue by Market  The following tables set forth, for the periods indicated, net revenue by market:     Three Months Ended  March 31, March 31,  2017 2016   Medical $ 11,671 $ 9,839  Hearing Health 5,619 6,468  Hearing Health Direct-to-Consumer 1,416 -  Professional Audio Communications 1,382 1,757  Total Revenue $ 20,088 $ 18,064 

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2017
Subsequent Events [Abstract]
Subsequent Events	 14. Subsequent Events  On May 3, 2017, IntriCon, Inc., a wholly owned subsidiary of the Company, entered into an Investment Agreement with Rheinton GmbH and Soundperience GmbH, each of which is a German company with limited liability, pursuant to which IntriCon, Inc. ultimately will acquire a 49% interest in Soundperience, a self-fitting hearing aid technology provider. Under the Investment Agreement, IntriCon, Inc. acquired a 16.67% interest in Soundperience in settlement of a 400 € loan (approximately $440 ) made by IntriCon, Inc. and will acquire a 32.33% interest in Soundperience for an additional investment of 800 € (approximately $880 ) upon the satisfaction of certain milestones for the development of self-fitting hearing aid software, anticipated to be completed in the 2017 fourth quarter. As part of the initial investment, IntriCon, Inc. entered into an irrevocable, worldwide license with Soundperience for the self-fitting hearing aid software. The license is exclusive in the United States.  The foregoing description of the Investment Agreement does not purport to be complete and is qualified in its entirety by reference to the English translation of the Investment Agreement, a copy of which is filed as Exhibit 10.4 hereto and is incorporated herein by reference.

Discontinued Operations (Tables

Discontinued Operations (Tables)	3 Months Ended
	Mar. 31, 2017
Cardiac Diagnostic Monitoring Business [Member]
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet	The following table shows the cardiac diagnostic monitoring business balance sheet as of December 31, 2016:    December 31,  2016  Accounts receivable, net $ 123  Current assets of discontinued operations $ 123   Accounts payable 22  Accrued compensation and other liabilities 101  Current liabilities of discontinued operations $ 123  The following table shows the results of the cardiac diagnostic monitoring discontinued operation s:    Three Months Ended  March 31, March 31,  2017 2016   Sales, net $ 140 $ 194  Operating costs and expenses (253) (494)  Net loss from discontinued operations (113) (300)  The Company sold the cardiac diagnostic monitoring business on F ebruary 17, 2017 to Datrix, LLC for a future revenue earn-out that was valued by the Company at $0. The Company recorded a loss on the sale of $164. The net loss was computed as follows:     Accounts receivable, net $ 179  Accrued liabilities (15)  Net assets sold $ 164  Fair value of consideration received -  Loss on sale of discontinued operations, net of income taxes $ 164 

Segment Reporting (Tables)

Segment Reporting (Tables)	3 Months Ended
	Mar. 31, 2017
Segment Reporting and Geogrpahic Information [Abstract]
Summary Of Data By Industry Segment	  At and for the Three Months Ended March 31, 2017 Body Worn Devices Hearing Health Direct-to-Consumer Total  Revenue, net $ 18,672 $ 1,416 $ 20,088  Loss from continuing operations (83) (453) (536)  Identifiable assets (excluding goodwill) 30,416 4,036 34,452  Goodwill 9,551 1,004 10,555  Depreciation and amortization 495 67 562  Capital expenditures 213 60 273  

Geographic Information (Tables)

Geographic Information (Tables)	3 Months Ended
	Mar. 31, 2017
Segment Reporting and Geogrpahic Information [Abstract]
Geographical Distribution Of Long-Lived Assets, Net	   March 31, December 31,  2017 2016  United States $ 4,572 $ 4,640  Singapore 1,339 1,413  Other – primarily United Kingdom and Indonesia 536 553  Consolidated $ 6,447 $ 6,606 
Geographical Distribution Of Net Sales	   Three Months Ended  Net Sales to Geographical Areas March 31, 2017 March 31, 2016   United States $ 15,523 $ 11,730  Europe 2,478 3,297  Asia 1,910 2,868  All other countries 177 169  Consolidated $ 20,088 $ 18,064 

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Mar. 31, 2017
Inventories [Abstract]
Schedule Of Inventories	   Raw materials Work-in process Finished products and components Total  March 31, 2017  Domestic $ 6,212 $ 1,401 $ 2,955 $ 10,568  Foreign 1,583 369 719 2,671  Total $ 7,795 $ 1,770 $ 3,674 $ 13,239   December 31, 2016  Domestic $ 5,731 $ 1,324 $ 2,609 $ 9,664  Foreign 1,751 284 644 2,679  Total $ 7,482 $ 1,608 $ 3,253 $ 12,343 

Short And Long-Term Debt (Table

Short And Long-Term Debt (Tables)	3 Months Ended
	Mar. 31, 2017
Short And Long-Term Debt [Abstract]
Summary Of Short And Long-Term Debt	   March 31, December 31,  2017 2016   Domestic asset-based revolving credit facility $ 4,078 $ 3,218  Note payable 2,000 2,000  Foreign overdraft and letter of credit facility 1,247 1,243  Domestic term loan 5,000 5,250  Unamortized finance costs (127) (81)  Total debt 12,198 11,630  Less: current maturities (2,368) (2,346)  Total long-term debt $ 9,830 $ 9,284 

Income Taxes (Tables)

Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2017
Income Taxes [Abstract]
Income (Loss) Before Income Taxes By Jurisdiction	   Three Months Ended  March 31, 2017 March 31, 2016  United States $ (387) $ (32)  Singapore (93) 204  Indonesia 16 18  United Kingdom (125) 55  Germany 117 70  Income (loss) before income taxes $ (472) $ 315 

Shareholders' Equity And Stoc28

Shareholders' Equity And Stock-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2017
Common Stock And Stock Options [Abstract]
Schedule Of Stock Option Activity	   Weighted-average Aggregate  Number of Shares Exercise Price Intrinsic Value   Outstanding at December 31, 2016 1,385 $ 6.54  Options forfeited, cancelled or expired (4) 7.38  Options granted 145 6.90  Options exercised (26) 5.09   Outstanding at March 31, 2017 1,500 $ 6.60 $ 4,463   Exercisable at March 31, 2017 1,116 $ 6.48 $ 3,641   Available for future grant at December 31, 2016 404   Available for future grant at March 31, 2017 272 

Income (Loss) Per Share (Tables

Income (Loss) Per Share (Tables)	3 Months Ended
	Mar. 31, 2017
Income (Loss) Per Share [Abstract]
Reconciliation Between Basic And Diluted Earnings Per Share	  Three Months Ended  March 31, 2017 March 31, 2016  Numerator:  Income (loss) from continuing operations before income taxes and discontinued operations $ (536) $ 281  Loss on sale of discontinued operations (164)  Loss from discontinued operations, net of income taxes (113) (300)   Net loss (813) (19)   Less: loss allocated to non-controlling interest (385) (34)   Net income (loss) attributable to shareholders $ (428) $ 15   Denominator:  Basic – weighted shares outstanding 6,826 5,981  Weighted shares assumed upon exercise of stock options - 247  Diluted – weighted shares outstanding 6,826 6,228   Basic income (loss) per share attributable to IntriCon shareholders:  Continuing operations $ (0.02) $ 0.05  Discontinued operations (0.04) $ (0.05)  Net income (loss) per share: $ (0.06) $ 0.00   Diluted income (loss) per share attributable to IntriCon shareholders:  Continuing operations $ (0.02) $ 0.05  Discontinued operations (0.04) $ (0.05)  Net income (loss) per share: $ (0.06) $ 0.00 

Revenue By Market (Tables)

Revenue By Market (Tables)	3 Months Ended
	Mar. 31, 2017
Revenue By Market [Abstract]
Schedule Of Net Revenue By Market	   Three Months Ended  March 31, March 31,  2017 2016   Medical $ 11,671 $ 9,839  Hearing Health 5,619 6,468  Hearing Health Direct-to-Consumer 1,416 -  Professional Audio Communications 1,382 1,757  Total Revenue $ 20,088 $ 18,064 

General (Details)

General (Details)	3 Months Ended
	Mar. 31, 2017	May 03, 2017
Hearing Help Express (HHE) [Member]
Acquisition of remaining percentage stake	80.00%
Subsequent Event [Member] | Soundperience GmbH [Member]
Ownership interest		49.00%

Discontinued Operations (Narrat

Discontinued Operations (Narrative) (Details) - USD ($) $ in Thousands	Feb. 17, 2017	Mar. 31, 2017
Loss on sale of discontinued operations, net of income taxes		$ (164)
Cardiac Diagnostic Monitoring Business [Member] | Discontinued Operations, Disposed of by Sale [Member]
Loss on sale of discontinued operations, net of income taxes	$ 164

Discontinued Operations (Schedu

Discontinued Operations (Schedule Of Discontinued Operations Balance Sheet) (Details) - USD ($) $ in Thousands	Feb. 17, 2017	Dec. 31, 2016
Current assets of discontinued operations		$ 123
Current liabilities of discontinued operations		123
Discontinued Operations, Disposed of by Sale [Member] | Cardiac Diagnostic Monitoring Business [Member]
Accounts receivable, net	$ 179	123
Current assets of discontinued operations		123
Accounts payable		22
Accrued compensation and other liabilities		101
Current liabilities of discontinued operations		$ 123

Discontinued Operations (Summar

Discontinued Operations (Summary Of Results Of Discontinued Operations) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Net loss from discontinued operations	$ (113)	$ (300)
Cardiac Diagnostic Monitoring Business [Member] | Discontinued Operations, Disposed of by Sale [Member]
Sales, net	140	194
Operating costs and expenses	(253)	(494)
Net loss from discontinued operations	$ (113)	$ (300)

Discontinued Operations (Sche35

Discontinued Operations (Schedule Of Loss On Sale Of Discontinued Operations) (Details) - USD ($) $ in Thousands	Feb. 17, 2017	Mar. 31, 2017	Dec. 31, 2016
Loss on sale of discontinued operations, net of income taxes		$ 164
Discontinued Operations, Disposed of by Sale [Member] | Cardiac Diagnostic Monitoring Business [Member]
Accounts receivable, net	$ 179		$ 123
Accrued liabilities	(15)
Net assets sold	164
Loss on sale of discontinued operations, net of income taxes	$ (164)

Segment Reporting (Narrative) (

Segment Reporting (Narrative) (Details)	3 Months Ended
	Mar. 31, 2017segment
Segment Reporting and Geogrpahic Information [Abstract]
Number of reportable segments	2

Segment Reporting (Summary Of D

Segment Reporting (Summary Of Data By Industry Segment) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Revenue, net	$ 20,088	$ 18,064
Income (loss) from operations	(536)	281
Identifiable assets (excluding goodwill)	34,452
Goodwill	10,555		$ 10,555
Depreciation and amortization	562	494
Capital expenditures	273	$ 624
Body Worn Devices [Member]
Revenue, net	18,672
Income (loss) from operations	(83)
Identifiable assets (excluding goodwill)	30,416
Goodwill	9,551
Depreciation and amortization	495
Capital expenditures	213
Hearing Health Direct-to-Consumer [Member]
Revenue, net	1,416
Income (loss) from operations	(453)
Identifiable assets (excluding goodwill)	4,036
Goodwill	1,004
Depreciation and amortization	67
Capital expenditures	$ 60

Geographic Information (Narrati

Geographic Information (Narrative) (Details) - customer	3 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Net Sales [Member] | One Customer [Member]
Revenue, Major Customer [Line Items]
Number of customers	1	1
Percentage of sales and/or receivables	46.00%	39.00%
Accounts Receivable [Member] | Two Customers [Member]
Revenue, Major Customer [Line Items]
Number of customers	2		2
Percentage of sales and/or receivables	31.00%		31.00%

Geographic Information (Geograp

Geographic Information (Geographical Distribution Of Long-Lived Assets, Net) (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Revenues from External Customers and Long-Lived Assets [Line Items]
Consolidated	$ 6,447	$ 6,606
United States [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Consolidated	4,572	4,640
Singapore [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Consolidated	1,339	1,413
Other - primarily United Kingdom and Indonesia [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Consolidated	$ 536	$ 553

Geographic Information (Geogr40

Geographic Information (Geographical Distribution Of Net Sales) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 20,088	$ 18,064
United States [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	15,523	11,730
Europe [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	2,478	3,297
Asia [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	1,910	2,868
All Other Countries [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 177	$ 169

Inventories (Schedule Of Invent

Inventories (Schedule Of Inventories) (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Inventory [Line Items]
Raw materials	$ 7,795	$ 7,482
Work-in process	1,770	1,608
Finished products and components	3,674	3,253
Total	13,239	12,343
United States [Member]
Inventory [Line Items]
Raw materials	6,212	5,731
Work-in process	1,401	1,324
Finished products and components	2,955	2,609
Total	10,568	9,664
Foreign [Member]
Inventory [Line Items]
Raw materials	1,583	1,751
Work-in process	369	284
Finished products and components	719	644
Total	$ 2,671	$ 2,679

Short And Long-Term Debt (Narra

Short And Long-Term Debt (Narrative) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Short And Long-Term Debt Instrument [Line Items]
Interest expense	$ 182,000	$ 126,000
International Credit [Member]
Short And Long-Term Debt Instrument [Line Items]
Weighted average interest rate of debt instruments	3.87%		3.50%
Credit facility, outstanding balance	$ 1,247,000		$ 1,243,000
Credit facility, available borrowing capacity	476,000		$ 455,000
Domestic Term-Loan [Member]
Short And Long-Term Debt Instrument [Line Items]
Loan amount	6,000,000
Quarterly installments	$ 250,000
Percentage of proceeds from certain asset sales required to pay down term loan	100.00%
Revolving Credit Facility [Member]
Short And Long-Term Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity	$ 9,000,000
Weighted average interest rate of debt instruments	6.82%		4.36%
Credit facility, outstanding balance	$ 4,078,000		$ 3,218,000
Credit facility, available borrowing capacity	4,508,000		$ 5,121,000
Letters Of Credit [Member]
Short And Long-Term Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity	$ 200,000
International Credit Facility [Member] | Minimum [Member]
Short And Long-Term Debt Instrument [Line Items]
Basis spread on variable rate of debt instruments	0.75%
International Credit Facility [Member] | Maximum [Member]
Short And Long-Term Debt Instrument [Line Items]
Basis spread on variable rate of debt instruments	2.50%
Hearing Help Express (HHE) [Member] | Note Payable [Member]
Short And Long-Term Debt Instrument [Line Items]
Debt	$ 2,000,000
Debt instrument, frequency of periodic payment, months	P48M
Ownership percentage held by third party	80.00%
Notes payable, interest rate	5.00%
Interest only payment term	12 months

Short And Long-Term Debt (Summa

Short And Long-Term Debt (Summary Of Short And Long-Term Debt) (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Unamortized finance costs	$ (127)	$ (81)
Total Debt	12,198	11,630
Less: Current maturities	(2,368)	(2,346)
Total long-term debt	9,830	9,284
Domestic Asset-Based Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Total Debt	4,078	3,218
Note Payable [Member]
Debt Instrument [Line Items]
Total Debt	2,000	2,000
Foreign Overdraft And Letter Of Credit Facility [Member]
Debt Instrument [Line Items]
Total Debt	1,247	1,243
Domestic Term-Loan [Member]
Debt Instrument [Line Items]
Total Debt	$ 5,000	$ 5,250

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Income Taxes [Abstract]
Income tax expense	$ 64	$ 34

Income Taxes (Income (Loss) Bef

Income Taxes (Income (Loss) Before Income Taxes By Jurisdiction) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Operating Loss Carryforwards [Line Items]
Income (loss) from continuing operations before income taxes and discontinued operations	$ (472)	$ 315
USA [Member]
Operating Loss Carryforwards [Line Items]
Income (loss) before income taxes, United States	(387)	(32)
Singapore Tax Authority [Member]
Operating Loss Carryforwards [Line Items]
Income (loss) before income taxes, Foreign	(93)	204
Indonesia [Member]
Operating Loss Carryforwards [Line Items]
Income (loss) before income taxes, Foreign	16	18
United Kingdom [Member]
Operating Loss Carryforwards [Line Items]
Income (loss) before income taxes, Foreign	(125)	55
Germany [Member]
Operating Loss Carryforwards [Line Items]
Income (loss) before income taxes, Foreign	$ 117	$ 70

Shareholders' Equity And Stoc46

Shareholders' Equity And Stock-Based Compensation (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate number of shares of common stock for which awards can be granted	272,000		404,000
Weighted average fair value of options granted	$ 3.98	$ 7.58
Estimated forfeiture rate of stock options	0.00%
Weighted average remaining contractual life of options exercisable, years	4 years 4 months 10 days		5 years 3 months 29 days
Stock option expense	$ 218	$ 181
Unrecognized compensation costs related to non-vested awards	$ 1,247
Unrecognized compensation costs related to non-vested awards, recognition period	2 years 15 days
2006 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate number of shares of common stock for which awards can be granted	1,124,000
Management Purchase Program [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares purchased for award	0	0
Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares purchased for award	4,000	4,000
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term of options	10 years
Maximum [Member] | Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum number of shares approved under purchase plan	300,000

Shareholders' Equity And Stoc47

Shareholders' Equity And Stock-Based Compensation (Schedule Of Stock Option Activity) (Details) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2017USD ($)$ / sharesshares
Common Stock And Stock Options [Abstract]
Number of Shares, Outstanding	1,385
Number of Shares, Options forfeited, cancelled or expired	(4)
Number of Shares, Options granted	145
Number of Shares, Options exercised	(26)
Number of Shares, Outstanding	1,500
Number of Shares, Exercisable	1,116
Number of Shares, Available for future grant at beginning of period	404
Number of Shares, Available for future grant at end of period	272
Weighted-average Exercise Price, Outstanding | $ / shares	$ 6.54
Weighted-average Exercise Price, Options forfeited or cancelled | $ / shares	7.38
Weighted-average Exercise Price, Options granted | $ / shares	6.90
Weighted-average Exercise Price, Options exercised | $ / shares	5.09
Weighted-average Exercise Price, Outstanding | $ / shares	6.60
Weighted-average Exercise Price, Exercisable | $ / shares	$ 6.48
Aggregate Intrinsic Value, Outstanding | $	$ 4,463
Aggregate Intrinsic Value, Exercisable | $	$ 3,641

Income (Loss) Per Share (Narrat

Income (Loss) Per Share (Narrative) (Details) shares in Thousands	3 Months Ended
	Mar. 31, 2017shares
Income (Loss) Per Share [Abstract]
Securities excluded from computation of diluted income per share	294

Income (Loss) Per Share (Reconc

Income (Loss) Per Share (Reconciliation Between Basic And Diluted Earnings Per Share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Income (Loss) Per Share [Abstract]
Income (loss) from continuing operations before discontinued operations	$ (536)	$ 281
Loss on sale of discontinued operations (Note 3)	(164)
Loss from discontinued operations, net of income taxes	(113)	(300)
Net loss	(813)	(19)
Less: Loss allocated to non-controlling interest	(385)	(34)
Net income (loss) attributable to IntriCon shareholders	$ (428)	$ 15
Basic - weighted shares outstanding	6,826	5,981
Weighted shares assumed upon exercise of stock options		247
Diluted - weighted shares outstanding	6,826	6,228
Continuing operations	$ (0.02)	$ 0.05
Discontinued operations	(0.04)	(0.05)
Basic	(0.06)	0
Continuing operations	(0.02)	0.05
Discontinued operations	(0.04)	(0.05)
Diluted	$ (0.06)	$ 0

Legal Proceedings (Details)

Legal Proceedings (Details) $ in Thousands	Mar. 31, 2017USD ($)
Contigencies And Commitments [Abstract]
Selas SAS, Liabilities	$ 450

Related-Party Transactions (Det

Related-Party Transactions (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Related-Party Transactions [Abstract]
Total base rent expense, real estate taxes and other charges	$ 124	$ 121
Legal services and costs	$ 72	$ 67

Revenue By Market (Schedule Of

Revenue By Market (Schedule Of Net Revenue By Market)(Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Revenue, Major Customer [Line Items]
Total Revenue	$ 20,088	$ 18,064
Medical [Member]
Revenue, Major Customer [Line Items]
Total Revenue	11,671	9,839
Hearing Health [Member]
Revenue, Major Customer [Line Items]
Total Revenue	5,619	6,468
Hearing Health - Direct To Customer [Member]
Revenue, Major Customer [Line Items]
Total Revenue	1,416
Professional Audio Communications [Member]
Revenue, Major Customer [Line Items]
Total Revenue	$ 1,382	$ 1,757

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member] € in Thousands, $ in Thousands	May 03, 2017EUR (€)	May 03, 2017USD ($)
Soundperience GmbH [Member]
Subsequent Event [Line Items]
Ownership interest	49.00%	49.00%
Soundperience GmbH Step One [Member]
Subsequent Event [Line Items]
Ownership interest	16.67%	16.67%
Business Acquisition, Cost of Acquired Entity, Purchase Price	€ 400	$ 440
Soundperience GmbH Step Two [Member]
Subsequent Event [Line Items]
Ownership interest	32.33%	32.33%
Business Acquisition, Cost of Acquired Entity, Purchase Price	€ 800	$ 880